RxDoctor Payments Data

Keith Clement, NP

Adult Health · Lynbrook, NYNPI 1528058732

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $13,135 of the $16,420 with a category attached, or 80.0%. 16 manufacturers reported payments, led by Relievant Medsystems, Inc. at 29.7% of the total. Among adult health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,420in general payments, 2019–2025

Across 382 payments — averaging $42.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Relievant Medsystems, Inc.$5K
  • Medtronic$4K
  • Boston Scientific$4K
  • Nevro Corp.$918
  • Globus Medical$678
  • Collegium Pharmaceutical, Inc.$461
  • plus $2K from 10 others

What the payments were for

  • Speaking & faculty fees$7505%
  • Travel & lodging$2,42715%
  • Food & beverage$13,13580%
  • Education$1081%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,420 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$33,654
Medicare patients
175
Services billed
1,275

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nucynta ErTapentadol Hcl39$61,074
NucyntaTapentadol Hcl53$56,358
OxycontinOxycodone Hcl49$18,746
Pregabalin372$17,490
Xtampza ErOxycodone Myristate25$16,051
Diclofenac Sodium191$12,442
Lidocaine97$11,145
Oxycodone Hcl302$6,262
Gabapentin440$6,217
Buprenorphine33$5,757
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen161$5,527
Tizanidine Hcl414$4,634
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen247$4,372
Tramadol Hcl ErTramadol Hcl45$3,498
Duloxetine Hcl137$2,496

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta Er, Nucynta, Xtampza Er$461$133,482117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.

Other adult health in Lynbrook

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →